254076 Assessing the public health impact of personalized medicine

Tuesday, November 1, 2011: 4:50 PM

Sholom Wacholder, PhD , Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
     
Personalized medicine is the assignment of preventive measures or treatment interventions on the basis of individual characteristics. Evaluation of whether the performance of any specific personalized medicine program is better than the performance of a program that uses the same intervention strategy for everyone is essential. The public health perspective is crucial to this evaluation.

Learning Areas:
Biostatistics, economics
Chronic disease management and prevention
Clinical medicine applied in public health
Conduct evaluation related to programs, research, and other areas of practice
Epidemiology
Provision of health care to the public

Learning Objectives:
Describe opportunities and challenges for personalized medicine.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I engage in substantive and methodologic research that tries to evaluate whether using individual characteristics in determining interventions is worthwhile.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Annual Special Session: Personalized medicine in genomics era: Current progresses and future trends
See more of: Statistics